Rock Creek Pharmaceuticals Inc  

(Public, NASDAQ:RCPI)   Watch this stock  
Find more results for NASDAQ:STSI
0.132
+0.006 (4.76%)
After Hours: 0.138 +0.006 (4.47%)
Mar 2, 6:45PM EST  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 0.13 - 0.14
52 week 0.11 - 1.08
Open 0.13
Vol / Avg. 0.00/1.23M
Mkt cap 24.32M
P/E     -
Div/yield     -
EPS -0.23
Shares 193.00M
Beta 2.93
Inst. own 19%
Jan 12, 2015
Rock Creek Pharmaceuticals Inc at EBD Biotech Showcase
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin - -363.52%
Operating margin - -360.17%
EBITD margin - -356.70%
Return on average assets -326.09% -155.00%
Return on average equity - -207.92%
Employees 25 -
CDP Score - -

Address

2040 Whitfield Avenue, Suite 300
SARASOTA, FL 34243
United States - Map
+1-804-5271970 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Rock Creek Pharmaceuticals Inc, formerly Star Scientific, Inc., is a pharmaceutical company. The Company is engaged primarily in the sale of nutraceutical dietary supplements and related cosmetic products and in pursuing ongoing research and development by the Company´┐Żs subsidiary, RCP Development, Inc. of related dietary supplements and pharmaceutical products.

Officers and directors

Michael John Mullan Ph.D., M.D. Chairman of the Board, Chief Executive Officer
Age: 57
Bio & Compensation  - Reuters
Christopher C. Chapman M.D., Jr. President, Director
Age: 61
Bio & Compensation  - Reuters
Benjamin M. Dent Chief Financial Officer, Vice President - Operations, Treasurer, Secretary
Age: 64
Bio & Compensation  - Reuters
Lee M. Canaan Independent Director
Age: 57
Bio & Compensation  - Reuters
Edward J. McDonnell Independent Director
Age: 69
Bio & Compensation  - Reuters
Scott P. Sensenbrenner Independent Director
Age: 45
Bio & Compensation  - Reuters